bristol myers | Global Biopharmaceutical Company

Keyword	CPC	PCC	Volume	Score	Length of keyword
bristol myers	1.96	1	8791	94	13
bristol	1.52	0.7	2836	25	7
myers	1.78	0.3	2528	72	5

Keyword	CPC	PCC	Volume	Score
bristol myers squibb	0.19	0.6	1822	64
bristol-myers squibb oncology	1.13	0.2	4416	66
bristol myers	0.05	0.3	2547	15
bristol myers stock	1.71	0.3	8954	60
bristol myers squibb careers	1.23	0.5	5146	68
bristol myers squibb patient assistance form	1.8	1	5470	71
bristol myers squibb stock	0.09	0.8	5659	83
bristol myers stock price today	0.85	0.6	8804	77
bristol myers squibb logo	0.56	1	2134	94
bristol myers careers	0.99	0.6	4354	65
bristol myers squibb website	0.37	0.5	3017	94
bristol-myers squibb jobs	1.95	0.1	656	35
bristol myers squibb eliquis	0.41	0.9	8988	32
bristol myers squibb stock price	1.02	0.1	9578	27
bristol myers squibb patient assistance	1.32	0.8	4088	63
bristol myers patient assistance form	0.56	0.4	6110	52
bristol myers stock price	1.63	0.6	3735	91
bristol myers eliquis	0.93	1	50	29
bristol myers squibb summit nj	1.8	0.9	5560	69
bristol myers squibb investor relations	1.28	0.4	8870	37
bristol myers squibb seattle	0.93	0.9	1897	98
bristol myers investor relations	0.29	0.9	2660	16
bristol myers squibb eliquis assistance form	0.68	0.5	5193	100
bristol myers eliquis download application	1.63	0.5	9348	44
bristol myers squibb lawrenceville nj	1.09	0.8	3859	4
bristol myers squibb company	1.67	1	3854	97
bristol myers squibb foundation	0.64	0.9	1436	19
bristol myers squibb princeton nj	1.38	0.2	9613	97

Search Results related to bristol myers on Search Engine

Global Biopharmaceutical Company - Bristol Myers Squibb
bms.com

https://www.bms.com/

WEBIf you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

DA: 64 PA: 41 MOZ Rank: 48

Bristol Myers Squibb - Wikipedia
wikipedia.org

https://en.m.wikipedia.org/wiki/Bristol_Myers_Squibb

WEBThe Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

DA: 4 PA: 8 MOZ Rank: 9

Your Meaningful Career at Bristol Myers Squibb
bms.com

https://careers.bms.com/

WEBDiscover what it means to have a meaningful career. At Bristol Myers Squibb, you'll transform patients' lives and help them prevail over serious diseases.

DA: 59 PA: 6 MOZ Rank: 13

About us - Bristol Myers Squibb
bms.com

https://www.bms.com/about-us.html

WEBWe promote health equity and seek to improve the health outcomes of populations disproportionately affected by serious diseases. Learn about global biopharmaceutical innovator Bristol Myers Squibb, helping millions to fight cancer, cardiovascular disease, HIV/AIDS, and more.

DA: 76 PA: 15 MOZ Rank: 76

Products and medicines - Bristol Myers Squibb
bms.com

https://www.bms.com/patient-and-caregivers/our-medicines.html

WEBBristol Myers Squibb focuses on developing new medicines to address the unmet medical needs of patients with serious diseases. Explore comprehensive information about our products including dosage and safety information.

DA: 16 PA: 82 MOZ Rank: 27

Bristol Myers Squibb Reports Fourth Quarter and Full-Year …
bms.com

https://news.bms.com/news/details/2023/Bristol-Myers-Squibb-Reports-Fourth-Quarter-and-Full-Year-Financial-Results-for-2022/default.aspx

WEBFeb 2, 2023 · Bristol Myers Squibb provides its 2023 GAAP EPS guidance range of $4.03 - $4.33 and its non-GAAP EPS guidance range of $7.95 - $8.25. Key 2023 GAAP and non-GAAP line-item guidance assumptions are: Total revenues are expected to increase by approximately 2% at reported rates and approximately 2% excluding foreign exchange.

DA: 44 PA: 68 MOZ Rank: 69

Medical information for healthcare providers - Bristol Myers Squibb
bms.com

https://www.bms.com/healthcare-providers.html

WEBBristol Myers Squibb provides information and resources to healthcare providers (HCP) about our medicines with the goal of improving the health of patients. Discover our HCP resources today.

DA: 32 PA: 88 MOZ Rank: 43

Bristol Myers Squibb Strengthens and Diversifies Oncology …
bms.com

https://news.bms.com/news/details/2023/Bristol-Myers-Squibb-Strengthens-and-Diversifies-Oncology-Portfolio-With-Acquisition-of-Mirati-Therapeutics/default.aspx

WEBOct 8, 2023 · Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value Right Acquisition Brings KRAZATI® (adagrasib), a Best-in-Class KRASG12C Inhibitor Approved by the U.S. FDA for the Treatment of Patients with …

DA: 32 PA: 25 MOZ Rank: 49

Bristol Myers Squibb Strengthens Neuroscience Portfolio with
bms.com

https://news.bms.com/news/corporate-financial/2023/Bristol-Myers-Squibb-Strengthens-Neuroscience-Portfolio-with-Acquisition-of-Karuna-Therapeutics/default.aspx

WEBDec 22, 2023 · Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics. 12/22/2023. Category: Corporate/Financial News. Transaction Delivers KarXT, a First-in-Class M1 / M4 Muscarinic Receptor Agonist, with Differentiated Efficacy and Safety. KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as …

DA: 45 PA: 38 MOZ Rank: 13

Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
cnbc.com

https://www.cnbc.com/2023/10/08/bristol-myers-squibb-to-acquire-mirati-in-a-4point8-billion-deal.html

WEBOct 8, 2023 · Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can help offset ...

DA: 7 PA: 6 MOZ Rank: 37